IntroductionDiagnosis and Treatment of Hepatocellular Carcinoma
Section snippets
Diagnosis of Hepatocellular Carcinoma
Cirrhosis is the strongest and the most common known risk factor for hepatocellular carcinoma (HCC), particularly cirrhosis related to hepatitis C virus (HCV) and hepatitis B virus (HBV) infections.1, 2, 3 In addition, HBV acquired in the perinatal period and early childhood is associated with increased risk of HCC even in the absence of cirrhosis.
Treatment of HCC
The management of HCC involves multiple disciplines including hepatology, surgery, diagnostic and interventional radiology, oncology, and pathology. One has to consider several patient and tumor factors including the severity of underlying liver disease, tumor bulk, and associated comorbidities as well as several practice-setting factors including availability and expertise in surgical resection, transplantation, and ablative therapies.
References (103)
- et al.
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
Hepatology
(2003) - et al.
Improved survival with screening for hepatocellular carcinoma
Liver Transpl
(2000) - et al.
Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)
Am J Gastroenterol
(2002) - et al.
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
J Hepatol
(2001) - et al.
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population
Hepatology
(1995) - et al.
Serum α-fetoprotein levels and liver histology in patients with chronic hepatitis C
Am J Gastroenterol
(1998) - et al.
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis
Clin Gastroenterol Hepatol
(2005) - et al.
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model
Liver Transpl
(2003) - et al.
Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis
Am J Gastroenterol
(2003) - et al.
MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation
Hepatology
(2003)